1. Prognostic role of long non-coding RNA TUG1 expression in various cancers: a meta-analysis
    Yongping Zhou et al, 2017, Oncotarget CrossRef
  2. Effect of ingredients from Chinese herbs on enterovirus D68 production
    Xiangling Meng et al, 2019, Phytotherapy Research CrossRef
  3. Oridonin inhibits bladder cancer survival and immune escape by covalently targeting HK1
    Shuangjie Liu et al, 2024, Phytomedicine CrossRef
  4. Recent progress of oridonin and its derivatives for cancer therapy and drug resistance
    Yong-Feng Guan et al, 2021, Medicinal Chemistry Research CrossRef
  5. Structural modification of oridonin via DAST induced rearrangement
    Dong-Dong Luo et al, 2018, RSC Advances CrossRef
  6. Coxsackievirus A6 Induces Cell Cycle Arrest in G0/G1 Phase for Viral Production
    Zengyan Wang et al, 2018, Frontiers in Cellular and Infection Microbiology CrossRef
  7. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma
    Han Wang et al, 2017, European Journal of Pharmacology CrossRef
  8. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
    Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
  9. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review
    Zhicheng Wei et al, 2023, Journal of Ethnopharmacology CrossRef
  10. Tranquilizing and Awakening ATM to Promote Killing of Cancer Cells
    Yi Chieh Lim et al, 2018, Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs CrossRef
  11. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway
    Jing Yang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  12. Recent advances in oridonin derivatives with anticancer activity
    Pedro J. M. Sobral et al, 2023, Frontiers in Chemistry CrossRef
  13. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef